日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study

利索卡巴吉内马拉鲁塞用于不适合接受造血干细胞移植的复发/难治性大B细胞淋巴瘤患者:2期试点研究的最终结果

Sehgal, Alison; Hoda, Daanish; Riedell, Peter A; Ghosh, Nilanjan; Hamadani, Mehdi; Hildebrandt, Gerhard C; Godwin, John E; Reagan, Patrick M; Wagner-Johnston, Nina D; Essell, James; Nath, Rajneesh; Solomon, Scott R; Champion, Rebecca; Licitra, Edward; Fanning, Suzanne; Gupta, Neel K; Chow, Victor A; Yuan, Brenda; Yang, Zhi; Ogasawara, Ken; Thorpe, Jerill; Gordon, Leo I

NKTR-255 enhances complete response following CD19 CAR T-cell therapy in patients with relapsed/refractory large B-cell lymphoma

NKTR-255可增强复发/难治性大B细胞淋巴瘤患者接受CD19 CAR T细胞治疗后的完全缓解率

Ahmed, Sairah; DiPersio, John; Essell, James; Diefenbach, Catherine; Perales, Miguel-Angel; Castilla-Llorente, Cristina; Dahiya, Saurabh; Liu, Yi; Xu, Heng; Fanton, Christie; Chaudhry, Sohail; Lee, Zachary H; Marcondes, A Mario Q; Tagliaferri, Mary A; Zalevsky, Jonathan; Miklos, David; Turtle, Cameron J; McGuirk, Joseph

Erratum: Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia

更正:快速识别供体可提高高危急性髓系白血病首次缓解患者的生存率

Pagel, John M; Othus, Megan; Garcia-Manero, Guillermo; Fang, Min; Radich, Jerald P; Rizzieri, David A; Marcucci, Guido; Strickland, Stephen A; Litzow, Mark R; Savoie, M Lynn; Spellman, Stephen R; Confer, Dennis L; Chell, Jeffrey W; Brown, Maria; Medeiros, Bruno C; Sekeres, Mikkael A; Lin, Tara L; Uy, Geoffrey L; Powell, Bayard L; Bayer, Ruthee-Lu; Larson, Richard A; Stone, Richard M; Claxton, David; Essell, James; Luger, Selina M; Mohan, Sanjay R; Moseley, Anna; Erba, Harry P; Appelbaum, Frederick R

Outpatient axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma: ZUMA-24 primary analysis

门诊使用axicabtagene ciloleucel治疗复发/难治性大B细胞淋巴瘤:ZUMA-24初步分析

Leslie, Lori A; Baird, John H; Flinn, Ian W; Tees, Michael; Hoda, Daanish; Deol, Abhinav; Young, Patricia; McClune, Brian; Varadarajan, Indumathy; Essell, James; Fanning, Suzanne; Simmons, Gary; Clark, William; Rapoport, Aaron P; Rodriguez, Tulio E; Winters, Joshua N; Davis, Madison; Miao, Harry M; Ray, Markqayne; Fang, Xiang; Kim, Jenny J; Oluwole, Olalekan O

A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML

一项随机III期研究,比较标准剂量与高剂量阿糖胞苷联合或不联合伏立诺他治疗急性髓系白血病(AML)的疗效。

Garcia-Manero, Guillermo; Podoltsev, Nikolai A; Othus, Megan; Pagel, John M; Radich, Jerald P; Fang, Min; Rizzieri, David A; Marcucci, Guido; Strickland, Stephen A; Litzow, Mark R; Savoie, M Lynn; Medeiros, Bruno C; Sekeres, Mikkael A; Lin, Tara L; Uy, Geoffrey L; Powell, Bayard L; Kolitz, Jonathan E; Larson, Richard A; Stone, Richard M; Claxton, David; Essell, James; Luger, Selina M; Mohan, Sanjay R; Moseley, Anna; Appelbaum, Frederick R; Erba, Harry P

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease

使用 Belumosudil (KD025) 抑制 ROCK2 治疗慢性移植物抗宿主病

Jagasia, Madan; Lazaryan, Aleksandr; Bachier, Carlos R; Salhotra, Amandeep; Weisdorf, Daniel J; Zoghi, Behyar; Essell, James; Green, Laurie; Schueller, Olivier; Patel, Jeegar; Zanin-Zhorov, Alexandra; Weiss, Jonathan M; Yang, Zhongming; Eiznhamer, David; Aggarwal, Sanjay K; Blazar, Bruce R; Lee, Stephanie J

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies

umbralisib(一种双重PI3Kδ/CK1ε抑制剂)在复发/难治性淋巴瘤中的综合安全性分析

Davids, Matthew S; O'Connor, Owen A; Jurczak, Wojciech; Samaniego, Felipe; Fenske, Timothy S; Zinzani, Pier Luigi; Patel, Manish R; Ghosh, Nilanjan; Cheson, Bruce D; Derenzini, Enrico; Brander, Danielle M; Reeves, James A; Knopińska-Posłuszny, Wanda; Allan, John N; Phillips, Tycel; Caimi, Paolo F; Lech-Maranda, Ewa; Burke, John M; Agajanian, Richy; Pettengell, Ruth; Leslie, Lori A; Cheah, Chan Y; Fonseca, Gustavo; Essell, James; Chavez, Julio C; Pagel, John M; Sharman, Jeff P; Hsu, Yanzhi; Miskin, Hari P; Sportelli, Peter; Weiss, Michael S; Flinn, Ian W

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia

快速识别供体可提高高危急性髓系白血病首次缓解患者的生存率

Pagel, John M; Othus, Megan; Garcia-Manero, Guillermo; Fang, Min; Radich, Jerald P; Rizzieri, David A; Marcucci, Guido; Strickland, Stephen A; Litzow, Mark R; Savoie, M Lynn; Spellman, Stephen R; Confer, Dennis L; Chell, Jeffrey W; Brown, Maria; Medeiros, Bruno C; Sekeres, Mikkael A; Lin, Tara L; Uy, Geoffrey L; Powell, Bayard L; Bayer, Ruthee-Lu; Larson, Richard A; Stone, Richard M; Claxton, David; Essell, James; Luger, Selina M; Mohan, Sanjay R; Moseley, Anna; Erba, Harry P; Appelbaum, Frederick R

Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes

一项针对未经治疗的高危骨髓增生异常综合征患者的普拉西诺他联合阿扎胞苷的II期随机双盲研究

Garcia-Manero, Guillermo; Montalban-Bravo, Guillermo; Berdeja, Jesus G; Abaza, Yasmin; Jabbour, Elias; Essell, James; Lyons, Roger M; Ravandi, Farhad; Maris, Michael; Heller, Brian; DeZern, Amy E; Babu, Sunil; Wright, David; Anz, Bertrand; Boccia, Ralph; Komrokji, Rami S; Kuriakose, Philip; Reeves, James; Sekeres, Mikkael A; Kantarjian, Hagop M; Ghalie, Richard; Roboz, Gail J

A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia

评估快速输注奥法妥木单抗治疗既往接受过治疗的慢性淋巴细胞白血病患者安全性的 II 期试验

Donnellan, William; Berdeja, Jesus G; Shipley, Diana; Arrowsmith, Edward R; Wright, David; Lunin, Scott; Brown, Richard; Essell, James H; Flinn, Ian W